日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quantifying Disease Activity Despite Treatment with Tumor Necrosis Factor Inhibitors Among Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Real-World Results from the PPD CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

量化接受肿瘤坏死因子抑制剂治疗的银屑病关节炎和中轴型脊柱关节炎患者的疾病活动度:来自 PPD CorEvitas 银屑病关节炎/脊柱关节炎注册研究的真实世界结果

Mease, Philip; Ye, Xiaolan; Saffore, Christopher D; Parikh, Bhumik; Ciecinski, Sandra; Blachley, Taylor; Eliot, Melissa; Middaugh, Nicole; Ogdie, Alexis

Association Between Achievement of Clinical Disease Control and Improvement in Patient-Reported Outcomes and Quality of Life in Patients With Psoriatic Arthritis in the Phase 3 SELECT-PsA 1 and 2 Randomized Controlled Trials

SELECT-PsA 1 和 2 期随机对照试验中,银屑病关节炎患者临床疾病控制与患者报告结局和生活质量改善之间的关联

Kavanaugh, Arthur; Mease, Philip; Gossec, Laure; Ranza, Roberto; Tsuji, Shigeyoshi; Douglas, Kevin; Lane, Michael; Lippe, Ralph; Mittal, Manish; Gao, Tianming; Setty, Arathi; Ciecinski, Sandra; Aletaha, Daniel; Nash, Peter